← Back to Search

Behavioral Intervention

Prism Adaptation Therapy for Stroke Rehabilitation

N/A
Recruiting
Led By Anna M. Barrett, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has had a first right brain stroke >18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks after enrollment
Awards & highlights

Study Summary

This trial will test a brain scan to help Veterans after a right brain stroke to recover the ability to do daily activities.

Who is the study for?
This trial is for Veterans over 18 who've had their first right brain stroke within the last 1-4 months. They must be able to sit up, have vision better than 20/50 in both eyes, and give informed consent. It's not for those with other neurological disorders like Alzheimer's, previous left brain strokes or significant prior strokes visible on scans.Check my eligibility
What is being tested?
The study tests Prism Adaptation Therapy (PAT) as a rehabilitation method for spatial neglect after a right brain stroke. The therapy involves visuomotor training while wearing optical prisms over a period of ten days. Researchers aim to develop a brain scan test to identify candidates for PAT.See study design
What are the potential side effects?
While specific side effects are not detailed here, PAT generally involves visual distortion through prisms which may cause initial disorientation or discomfort but typically adapts over time during therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a stroke on the right side of my brain as an adult.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional independence Measure (FIM) improvement trajectory
Spatial neglect (SN) type (Aiming SN versus Where SN)
Secondary outcome measures
SN severity, as assessed by the Behavioral Inattention Test-conventional subtest (BIT-c)
SN severity, as assessed by the Catherine Bergego Scale (CBS)

Trial Design

2Treatment groups
Active Control
Group I: No spatial neglectActive Control1 Intervention
People without spatial neglect symptoms will not receive an intervention for spatial neglect.
Group II: Prism adaptation TherapyActive Control1 Intervention
People with spatial neglect will receive this effective treatment to reduce symptoms, which the investigators' previous work indicated may be particularly effective for Aiming SN symptoms.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,040 Total Patients Enrolled
2 Trials studying Spatial Neglect
57 Patients Enrolled for Spatial Neglect
Anna M. Barrett, MDPrincipal InvestigatorVA Central Western Massachusetts Healthcare System, Leeds, MA
1 Previous Clinical Trials
45 Total Patients Enrolled
1 Trials studying Spatial Neglect
45 Patients Enrolled for Spatial Neglect

Media Library

Prism Adaptation Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05983185 — N/A
Spatial Neglect Research Study Groups: No spatial neglect, Prism adaptation Therapy
Spatial Neglect Clinical Trial 2023: Prism Adaptation Therapy Highlights & Side Effects. Trial Name: NCT05983185 — N/A
Prism Adaptation Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05983185 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open recruitment slots for this research endeavor?

"Clinicaltrials.gov reveals that this clinical trial is still seeking participants; the initial posting being on February 1st 2023 and most recently revised on August 7th, 2023."

Answered by AI

How many patients are being accepted into this trial?

"Affirmative. According to information listed on clinicaltrials.gov, this trial is actively recruiting; it was initially posted online in February 1st of 2023 and updated lastly on August 7th of the same year. In total, 244 participants are needed from 3 distinct medical locations."

Answered by AI
~163 spots leftby Dec 2026